The Study
Metabolic Stress‐Induced Choline Kinase α (CHKA) Activation in Endothelial Subpopulation Contributes to Diabetes‐Associated Microvascular Dysfunction
This study found that a protein called CHKA is more active in the blood vessels of diabetic mice and some people with severe eye disease. It shows that when CHKA is turned down, the blood vessels get better—but this doesn't prove CHKA causes the problem in humans, just that they're linked.
Analysis score
Maximum 58 for a case-control study.
Where the score came from
In diabetes, some blood vessel cells in the eye turn on a special enzyme called CHKA, which makes them grow too much and leak fluid. This study found that turning off CHKA stops the leaks and bad growth.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 553 / 100
Quality score
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this suggests blocking CHKA could prevent vision loss in diabetics by stopping eye blood vessels from leaking and growing abnormally.
- 2CHKA was 2.5x higher in diseased eye vessels; silencing it reduced leaks by ~50% and bad blood vessel growth by ~40% in mice; NMN (a NAD+ booster) fixed half the damage.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Advanced Science
Year
2025
Authors
Ling Ren, Linyu Zhang, Yun Bai, Chang Huang, Xiaosa Li, Fanfei Ma, Wan Mu, Mudi Yao, Chang Jiang, Xiangjun Chen, Q. Jiang, Biao Yan
Related Content
Claims (7)
The blood vessels in the retina show changes that mirror changes in the heart and blood vessels throughout the body because both are exposed to the same metabolic and blood flow stresses.
Nicotinamide mononucleotide supplementation restores NAD+ levels and reverses impaired blood vessel formation caused by reduced CHKA activity in laboratory cell cultures and animal models.
People with genetic variants that lead to higher levels of choline kinase alpha have a higher likelihood of developing diabetic retinopathy.
In mice with diabetes, turning off the CHKA gene in blood vessel lining cells reduces abnormal leakage and cell death in the retina by altering NAD+ metabolism and increasing SIRT1-Notch signaling.
When choline kinase alpha (CHKA) is turned off in human retinal blood vessel cells, the cells show reduced ability to multiply, move, and form tube-like structures, and their NAD+ levels drop, demonstrating that CHKA is required for these angiogenic processes via metabolic regulation.
In diabetic retinopathy, reducing choline kinase alpha (CHKA) decreases SIRT1 and increases Notch pathway activity, leading to endothelial dysfunction; restoring NAD+ reverses these changes.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.